Maximum quantity allowed is 999
请选择数量
CAS RN: 109581-93-3 | 产品编码: M2258
Tacrolimus Monohydrate
×
![]()
×
技术规格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 80.0 area% |
| Melting point | 125.0 to 129.0 °C |
物性（参考值）
| 熔点 | 127 °C |
| 水溶性 | 不溶 |
| 溶解性（可溶于） | 丙酮, 乙醇, 甲醇 |
GHS
| 象形图 |
|
| 信号词 | Danger |
| 危险性说明 | H301 : Toxic if swallowed. |
| 防范说明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth. P405 : Store locked up. |
相关法规
| RTECS# | KD4201200 |
运输信息
| UN编号 | UN2811 |
| 类别 | 6.1 |
| 包装类别 | III |
| HS编码* | 2934.99-000 |
应用
Bone research
Reference
- In Vitro Bone Formation Induced by Immunosuppressive Agent Tacrolimus Hydrate (FK506)
应用
Tacrolimus: A Calcineurin Inhibitor with Immunosuppressive Properties
Tacrolimus, known as FK506, is a macrolide immunosuppressant produced by Streptomyces tsukubaensis. Tacrolimus is practically insoluble in water, freely soluble in ethanol and DMF, and very soluble in methanol and chloroform. Tacrolimus inhibits T-lymphocyte activation, although the exact mechanism of action is not known. Experimental evidence suggests that tacrolimus is inactive by itself and requires binding to an intracellular protein, FK506 binding protein-12 (FKBP-12), for activation in cells. A complex of tacrolimus-FKBP-12, calcium, calmodulin, and calcineurin (a calcium and calmodulin dependent protein phosphatase) is then formed and the phosphatase activity of calcineurin inhibited. This effect may prevent both T-lymphocyte signal transduction and IL-2 transcription. Cyclosporin A [C2408] also inhibits calcineurin but is less potent than tacrolimus. Tacrolimus is mainly metabolized by cytochrome P 450 IIIA (CYP3A) subfamilies. (The product is for research purpose only.)
References
- Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
- The mechanism of action of cyclosporin A and FK506
- Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex
- Drug target validation and identification of secondary drug target effects using DNA microarrays
- FK506, an immunosuppressant targeting calcineurin function (a review)
- Effects of FK506 and other immunosuppressive anti-rheumatic agents on T cell activation mediated IL-6 and IgM production in vitro
- Mechanisms of clinically relevant drug interactions associated with tacrolimus (a review)
参考文献
文档
技术文章
产品文档 (部分产品的分析图谱无法提供，敬请谅解。)
化学品安全说明书(SDS)
请选择语言。
如需更多帮助，请联系我 们。
技术规格
CoA及其他文档
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
示例 CoA
可下载CoA示例。注：该示例不一定是最新批次的CoA。
目前没有该产品的 CoA 示例。
分析图谱
请输入批号
批号输入有误。请输入中横线前的4-5个字母数字字符。
很抱歉，您搜索的分析图谱无法提供。